HomeLearnNews

News

January 18, 2016 / Treatment Updates

BLINCYTO is the First-and-Only Bispecific CD19-Directed CD3 T-Cell Engager (BiTE®) Immunotherapy Approved by Health Canada

Mississauga, ON. (January 12, 2016) - Amgen Canada Inc., today announced that Health Canada has granted conditional* approval of BLINCYTO™ (blinatumomab) for the treatment of adults with Philadelphia chromosome-negative (Ph-)...
Read More
January 18, 2016 / CCSN News

Health Ministers’ Meeting: Cancer Groups Support Improved Access for Cancer Patients Falling Between the Cracks

OTTAWA, January 20th, 2016 – Leading Canadian cancer groups, the Canadian Cancer Survivor Network (CCSN), Save Your Skin Foundation (SYSF), Life Saving Therapies Network (LSTN), Anal Cancer – A Bum...
Read More
January 14, 2016 / CCSN News

Webinar – Colorectal & Anal Cancer

Watch this webinar on YouTube!View the slides on SlideShare!Colorectal & Anal Cancer from Canadian Cancer Survivor Network   Webinar InformationThis webinar featured Helene Hutchings, chair of Anal Cancer – A Bum...
Read More
January 7, 2016 / CCSN News

World Cancer Day 2016 – WE CAN: Inspire Action, Take Action

The first step in driving progress around cancer is to push for actions that we know will improve survival rates and give cancer patients a better quality of life.  ...
Read More
January 7, 2016 / CCSN News

World Cancer Day 2016 – WE CAN: Work Together for Increased Impact

The global cancer burden can be reduced through synergistic partnerships between governments, civil society and the private sector, that leverage complementary skills, competencies and spheres of influence to accelerate progress...
Read More
January 7, 2016 / CCSN News

World Cancer Day 2016 – WE CAN: Shape Policy Change

The law and regulatory measures can be used effectively to reduce exposure to cancer risks including to tobacco, alcohol and unhealthy foods, as well as environmental exposures.   Tobacco taxation...
Read More
January 7, 2016 / CCSN News

World Cancer Day 2016 – WE CAN: Mobilize our Networks to Drive Progress

 Identifying and mobilising networks to support efforts to reduce the globalcancer burden goals are critical to strengthen advocacy efforts and build capacity through education and training1. For example, UICC as a...
Read More
January 6, 2016 / CCSN News

Share your experiences about living with Mantle Cell Lymphoma in CCSN’s survey!

The Leukemia & Lymphoma Society of Canada and The Canadian Cancer Survivor Network are seeking patient and caregiver input for the pan-Canadian Oncology Drug Review (pCODR) which will be reviewing...
Read More
January 5, 2016 / CCSN News

Participate in the Canadian Cancer Survivor Network Survey on trabectedin (Yondelis)!

The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of trabectedin (Yondelis) for the treatment of patients with...
Read More
December 16, 2015 / CCSN News

New cervical cancer portal provides essential information for Canadian women

Ottawa, December 10, 2015: The Canadian Cancer Survivor Network is pleased to announce the launch of its newest website portal on cervical cancer at https://survivornet.ca/en/cancer_basics/cervical_cancer_portal .Approximately 1,050 Canadian women are...
Read More
1 … 57 58 59 60 61 … 67